Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Type: Posters
- Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Presentations: 24
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P01.02 - Trastuzumab Deruxtecan Plus Pembrolizumab in Advanced/Metastatic Breast or Non-Small Cell Lung Cancer: A Phase 1b Study
00:00 - 00:00 | Presenter: Hossein Borghaei
- Abstract
Loading...
-
+
P09 - Health Services Research/Health Economics - Real World Outcomes
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 60
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P09.18 - COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)
00:00 - 00:00 | Author(s): Jennifer G. Whisenant
- Abstract
Loading...
-
+
P78 - Immunotherapy (Phase II/III Trials) - Immune Checkpoint Inhibitor Single Agent
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P78.01 - Nivolumab in Second Line Non-Small Cell Lung Cancer – Comparing Real-World Outcomes in England to CheckMate (CM) 017 and 057
00:00 - 00:00 | Presenter: Sanjay Popat
- Abstract
Loading...
-
+
P87 - Targeted Therapy - Clinically Focused - RET
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 5
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P87.02 - AcceleRET Lung: A Phase 3 Study of First-Line Pralsetinib in Patients with RET-Fusion+ Advanced/Metastatic NSCLC
00:00 - 00:00 | Presenter: Benjamin Besse
- Abstract
Loading...
-
+
ES18 - The Future of Immunotherapy in Unresectable Mesothelioma
- Type: Educational Session
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 4
- Coordinates: 1/30/2021, 16:45 - 17:45, Scientific Program Auditorium
-
+
ES18.01 - Immunotherapy – Current State of Play (Concentrating on Current Data for First Line and Salvage Strategies)
16:45 - 17:00 | Presenter: Sanjay Popat
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.